Rigrodsky & Long, P.A. Announces Investigation Of American Realty Capital Trust, Inc. Buyout
07 Septiembre 2012 - 3:52PM
Business Wire
Rigrodsky & Long, P.A. announces that it is investigating
potential legal claims against the board of directors of American
Realty Capital Trust, Inc. (“ARCT” or the “Company”) (NASDAQ GS:
ARCT) regarding possible breaches of fiduciary duties and other
violations of law related to the Company’s entry into an agreement
to be acquired by Realty Income Corporation (“Realty Income”)
(NYSE: O) in a transaction valued at approximately $2.95 billion,
including debt.
Click here to learn more:
http://www.rigrodskylong.com/investigations/american-realty-capital-trust-arct.
Under the terms of the proposal, public shareholders of ARCT
will receive 0.2874 shares of Realty Income stock for each share of
ARCT they own. Based on Realty Income’s closing price on September
5, 2012 of $42.48, the total value would be approximately $12.21
for each share of ARCT owned.
The investigation concerns whether ARCT’s board of directors
failed to adequately shop the Company and obtain the best possible
value for ARCT’s shareholders before entering into an agreement
with Realty Income. According to Yahoo! Finance, at least one
analyst has set a price target for ARCT stock at $13.00 per
share.
If you own the common stock of ARCT and purchased your shares
before September 6, 2012, if you have information or would like to
learn more about these claims, or if you wish to discuss these
matters or have any questions concerning this announcement or your
rights or interests with respect to these matters, please contact
Peter Allocco at Rigrodsky & Long, P.A., 825 East Gate
Boulevard, Suite 300, Garden City, New York 11530 toll free at
(888) 969-4242, by e-mail to info@rigrodskylong.com, or at:
http://www.rigrodskylong.com/investigations/american-realty-capital-trust-arct.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware
and Garden City, New York, regularly prosecutes securities class,
derivative and direct actions, shareholder rights litigation and
corporate governance litigation, on behalf of shareholders in
states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar
outcome.
Arcturus Therapeutics (NASDAQ:ARCT)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Arcturus Therapeutics (NASDAQ:ARCT)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024